Janssen Research & Development, LLC is a pharmaceutical research company that is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. It focuses on innovative healthcare solutions by conducting research in areas such as immunology, oncology, neuroscience, infectious diseases, and cardiovascular diseases. Committed to advancing the science across multiple domains, Janssen aims to develop new therapies that improve patient outcomes and quality of life. Through robust collaboration with partners, the company emphasizes the importance of scientific innovation and is involved in the clinical development of drugs from initial concept through regulatory approval.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#8 in Raritan, NJ

#1,104 in New Jersey

#29,882 in US

#56,092 in the World

Raritan, NJ, United States of America

Janssen Research & Development, LLC

Forward Citations = 0

45 inventors:

Margery Connelly (2 out of 6 patents)

Scott Ronald Brodeur (1 out of 14 patents)

Manuel Sepulveda (1 out of 21 patents)

4. Tom Parry (1 out of 10 patents)

5. Jian-Shen Qi (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Janssen Research & Development, LLC. Retrieved from https://idiyas.com/company/janssen-research-and-development

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]